Property News · July 3, 2024

FDA approves Eli Lilly’s Kisunla for Alzheimer’s treatment


Becomes the second drug in market to slow down the dreaded memory-loss disease; Will cost $32,000 for a 12-month treatment

Source : arabianbusiness.com
Read more…FDA approves Eli Lilly’s Kisunla for Alzheimer’s treatment